首页 | 本学科首页   官方微博 | 高级检索  
检索        

复方苦参注射液联合TP方案治疗晚期NSCLC临床观察
引用本文:庞东生,许扬,汪雪原,宋志刚.复方苦参注射液联合TP方案治疗晚期NSCLC临床观察[J].实用全科医学,2011,9(1):50-50,164.
作者姓名:庞东生  许扬  汪雪原  宋志刚
作者单位:海军安庆医院肿瘤内科;
摘    要:目的观察复方苦参注射液联合化疗治疗晚期非小细胞肺癌的疗效与不良反应。方法62例晚期非小细胞肺癌的患者,随机分为对照组30例:紫杉醇135mg/m^2,d1,静滴;顺铂30mg/m^2,d1-3静滴(TP方案)和治疗组32例:复方苦参注射液联合TP方案,两组病例的临床资料具有可比性。两组患者的治疗,均每21d为1个治疗周期,3个周期为一疗程。结果两组患者中,治疗组在近期疗效、卡氏评分、控制疼痛及不良反应等方面都优于对照组,P〈0.05。结论TP方案联合中药复方苦参注射液治疗非小细胞肺癌具有较好的耐受性和安全性,近期疗效等优于对照组。

关 键 词:晚期非小细胞肺癌  复方苦参注射液  化疗

Clinical Effects of TP Project Combined with Compound Matrine Injections on Advanced Non-Small-Cell Lung Cancer
PANG Dong-sheng,XU Yang,WANG Xue-yuan,et al..Clinical Effects of TP Project Combined with Compound Matrine Injections on Advanced Non-Small-Cell Lung Cancer[J].Applied Journal Of General Practice,2011,9(1):50-50,164.
Authors:PANG Dong-sheng  XU Yang  WANG Xue-yuan  
Institution:PANG Dong-sheng,XU Yang,WANG Xue-yuan,et al.Department of Internal Medicine Oncology,Anqing Naval Hospital,Anqing 246003,Anhui,China
Abstract:Objective To observe the effect of compound matrine injections combined with chemotherapy on advanced non-small cell lung cancer(NSCLC) and its side effects.Methods Sixty two patients with advanced NSCLC were randomly divided into two groups:the control group(30 cases) received TP regimen(paclitaxel 135 mg/m2,d1,intravenous;cisplatin 30 mg/m2,d1~3 infusion);the experiment group(32 cases) received the combination therapy with compound matrine injections and TP regimen.The clinical data of two groups were com...
Keywords:Advanced non-small cell lung cancer  Compound matrine injections  Chemotherapy  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号